European Position Paper on Rhinosinusitis and Nasal Polyps 2020
- PMID: 32077450
- DOI: 10.4193/Rhin20.600
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
Abstract
The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the eight years since the EPOS2012 position paper was published and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery. EPOS2020 also involves new stakeholders, including pharmacists and patients, and addresses new target users who have become more involved in the management and treatment of rhinosinusitis since the publication of the last EPOS document, including pharmacists, nurses, specialised care givers and indeed patients themselves, who employ increasing self-management of their condition using over the counter treatments. The document provides suggestions for future research in this area and offers updated guidance for definitions and outcome measurements in research in different settings. EPOS2020 contains chapters on definitions and classification where we have defined a large number of terms and indicated preferred terms. A new classification of CRS into primary and secondary CRS and further division into localized and diffuse disease, based on anatomic distribution is proposed. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, allergic rhinitis, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. All available evidence for the management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is systematically reviewed and integrated care pathways based on the evidence are proposed. Despite considerable increases in the amount of quality publications in recent years, a large number of practical clinical questions remain. It was agreed that the best way to address these was to conduct a Delphi exercise . The results have been integrated into the respective sections. Last but not least, advice for patients and pharmacists and a new list of research needs are included. The full document can be downloaded for free on the website of this journal: http://www.rhinologyjournal.com.
Similar articles
-
EPOS2020: a major step forward.Rhinology. 2020 Feb 1;58(1):1. doi: 10.4193/Rhin20.401. Rhinology. 2020. PMID: 32078669
-
Executive summary of EPOS 2020 including integrated care pathways.Rhinology. 2020 Apr 1;58(2):82-111. doi: 10.4193/Rhin20.601. Rhinology. 2020. PMID: 32226949
-
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.Rhinology. 2012 Mar;50(1):1-12. doi: 10.4193/Rhino12.000. Rhinology. 2012. PMID: 22469599
-
EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary.Prim Care Respir J. 2008 Jun;17(2):79-89. doi: 10.3132/pcrj.2008.00029. Prim Care Respir J. 2008. PMID: 18438594 Free PMC article. Review.
-
[Chronic Rhinosinusitis - EPOS 2012 Part I].Laryngorhinootologie. 2013 Mar;92(3):193-201; quiz 202-3. doi: 10.1055/s-0033-1333704. Epub 2013 Feb 21. Laryngorhinootologie. 2013. PMID: 23430697 German.
Cited by
-
Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A "Real-Life" Observational Study in Naïve and Post-Surgical Patients.J Pers Med. 2022 Sep 17;12(9):1526. doi: 10.3390/jpm12091526. J Pers Med. 2022. PMID: 36143311 Free PMC article.
-
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.Annu Rev Immunol. 2021 Apr 26;39:719-757. doi: 10.1146/annurev-immunol-093019-125918. Epub 2021 Mar 1. Annu Rev Immunol. 2021. PMID: 33646859 Free PMC article.
-
Surgery for nasal polyposis in cystic fibrosis.Cochrane Database Syst Rev. 2023 Dec 8;12(12):CD014084. doi: 10.1002/14651858.CD014084.pub2. Cochrane Database Syst Rev. 2023. PMID: 38063253 Free PMC article. Review.
-
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?Int J Mol Sci. 2024 Jan 5;25(2):730. doi: 10.3390/ijms25020730. Int J Mol Sci. 2024. PMID: 38255804 Free PMC article. Review.
-
The Impact of Occupational Exposures on Chronic Rhinosinusitis: A Scoping Review.Explor Asthma Allergy. 2024;2(4):301-318. doi: 10.37349/eaa.2024.00046. Epub 2024 Jul 19. Explor Asthma Allergy. 2024. PMID: 39184021 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical